Xiaoli Yu

4.4k total citations
157 papers, 3.2k citations indexed

About

Xiaoli Yu is a scholar working on Cancer Research, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Xiaoli Yu has authored 157 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Cancer Research, 41 papers in Oncology and 35 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Xiaoli Yu's work include Breast Cancer Treatment Studies (44 papers), Breast Lesions and Carcinomas (24 papers) and Advanced Radiotherapy Techniques (21 papers). Xiaoli Yu is often cited by papers focused on Breast Cancer Treatment Studies (44 papers), Breast Lesions and Carcinomas (24 papers) and Advanced Radiotherapy Techniques (21 papers). Xiaoli Yu collaborates with scholars based in China, United States and South Korea. Xiaoli Yu's co-authors include Xiaomao Guo, S. Zhou, Zhaozhi Yang, Lawrence B. Marks, Donna Hollis, Michael A. Blazing, Terence Z. Wong, A. Tisch, Patricia H. Hardenbergh and Robert G. Prosnitz and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Xiaoli Yu

148 papers receiving 3.2k citations

Peers

Xiaoli Yu
Rudy Guerra United States
Philip Hahnfeldt United States
Puneeth Iyengar United States
Hubert Vesselle United States
Lizhi Liu China
Lynn Hlatky United States
Xiaoli Yu
Citations per year, relative to Xiaoli Yu Xiaoli Yu (= 1×) peers Baosheng Li

Countries citing papers authored by Xiaoli Yu

Since Specialization
Citations

This map shows the geographic impact of Xiaoli Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoli Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoli Yu more than expected).

Fields of papers citing papers by Xiaoli Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoli Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoli Yu. The network helps show where Xiaoli Yu may publish in the future.

Co-authorship network of co-authors of Xiaoli Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoli Yu. A scholar is included among the top collaborators of Xiaoli Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoli Yu. Xiaoli Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Zhile, Xiaoli Yu, Yu Guo, Kang Wei, & Xin Chen. (2025). A noise-enhanced feature extraction method combined with tunable Q-factor wavelet transform and its application to planet-bearing fault diagnosis. Applied Acoustics. 239. 110845–110845. 10 indexed citations
2.
Rao, Xinxin, Zhibin Qiao, Yang Yang, et al.. (2024). Unveiling Epigenetic Vulnerabilities in Triple-Negative Breast Cancer through 3D Organoid Drug Screening. Pharmaceuticals. 17(2). 225–225. 7 indexed citations
3.
Pan, Zhe, Li Zhang, Wei Shi, et al.. (2024). Dual Inhibition of CDK4/6 and CDK7 Suppresses Triple‐Negative Breast Cancer Progression via Epigenetic Modulation of SREBP1‐Regulated Cholesterol Metabolism. Advanced Science. 12(5). e2413103–e2413103. 1 indexed citations
4.
Rao, Xinxin, Xuanyi Wang, Kairui Jin, et al.. (2024). Outcomes with and without postmastectomy radiotherapy for pT3N0‐1M0 breast cancer: An institutional experience. Cancer Medicine. 13(1). e6927–e6927. 4 indexed citations
5.
Zhang, Li, Wei Shi, Zhaozhi Yang, et al.. (2024). CXCR6 expression correlates with radiotherapy response and immune context in triple-negative breast cancer–experimental studies. International Journal of Surgery. 110(8). 4695–4707. 3 indexed citations
6.
Yang, Zhaozhi, Jin Meng, Xin Mei, et al.. (2024). Brain Radiotherapy With Pyrotinib and Capecitabine in Patients With ERBB2-Positive Advanced Breast Cancer and Brain Metastases. JAMA Oncology. 10(3). 335–335. 10 indexed citations
8.
Jin, Meng, Xiaomeng Zhang, Li Zhang, et al.. (2023). The Role of Radiotherapy for Patients with Unresectable Locally Advanced Breast Cancer following Neoadjuvant Systemic Therapy. Journal of Oncology. 2023. 1–10. 5 indexed citations
10.
Zhang, Li, Jun Liu, Jinli Ma, et al.. (2022). Entire Versus Medial Supraclavicular Nodal Irradiation for Patients With High-Risk Node-Positive Breast Cancer. International Journal of Radiation Oncology*Biology*Physics. 114(1). 120–129. 3 indexed citations
11.
Zhang, Li, Xiaomeng Zhang, Jurui Luo, et al.. (2021). Impact of clinical-pathological factors on locoregional recurrence in mastectomy patients with T1-2N1 breast cancer: who can omit adjuvant radiotherapy?. Breast Cancer Research and Treatment. 190(2). 277–286. 6 indexed citations
12.
Zhang, Xiaomeng, Xingxing Chen, Jinli Ma, et al.. (2021). Clinicopathological Characteristics of Breast Ductal Carcinoma In Situ: An Analysis of Chinese Population of 617 Patients. Journal of Oncology. 2021. 1–6. 1 indexed citations
13.
Jin, Kairui, et al.. (2021). Characteristics, prognosis, risk factors, and management of recently diagnosed ductal carcinoma in situ with microinvasion. Cancer Medicine. 10(20). 7203–7212. 10 indexed citations
14.
Luo, Jurui, Kairui Jin, Xuanyi Wang, et al.. (2020). Biological subtype predicts locoregional recurrence after postmastectomy radiotherapy in Chinese breast cancer patients. Cancer Medicine. 9(7). 2427–2434. 8 indexed citations
15.
Wang, Xuanyi, Jurui Luo, Kairui Jin, et al.. (2019). Internal mammary node irradiation improves 8-year survival in breast cancer patients: results from a retrospective cohort study in real-world setting. Breast Cancer. 27(2). 252–260. 6 indexed citations
17.
Zhou, Zhirui, Xingxing Chen, Ruping Zhao, et al.. (2016). HER2 reduces breast cancer radiosensitivity by activating focal adhesion kinase in vitro and in vivo. Oncotarget. 7(29). 45186–45198. 59 indexed citations
18.
Qi, Songtao, Ye Song, Yu-Ping Peng, et al.. (2012). ZEB2 Mediates Multiple Pathways Regulating Cell Proliferation, Migration, Invasion, and Apoptosis in Glioma. PLoS ONE. 7(6). e38842–e38842. 149 indexed citations
19.
Ahn, Sung‐Ja, Daniel Kahn, S. Zhou, et al.. (2005). Dosimetric and clinical predictors for radiation-induced esophageal injury. International Journal of Radiation Oncology*Biology*Physics. 61(2). 335–347. 121 indexed citations
20.
Das, Shiva K., Alan H. Baydush, S. Zhou, et al.. (2004). Predicting radiotherapy‐induced cardiac perfusion defects. Medical Physics. 32(1). 19–27. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026